₨ 8,000
Cinnatropin somatropin 10mg/1.5ml Injection is a prescription medication containing recombinant human growth hormone (somatropin) used to treat growth disorders and growth hormone deficiency in children and adults. It is manufactured by CinnaGen and is available as a ready-to-use solution in a pre-filled pen.
Key Information
- Active Ingredient: Somatropin (recombinant human growth hormone).
- Strength: 10 mg of somatropin in 1.5 ml of solution.
- Manufacturer: CinnaGen.
- Administration: Subcutaneous injection (usually into the thigh, buttocks, or abdomen), with the injection site rotated to prevent skin problems. It is administered daily or as directed by a healthcare professional.
- Legal Status: Available by prescription only.
Indications for Use
CinnaTrophin is indicated for the treatment of various conditions, including:
- Growth failure in children due to inadequate secretion of endogenous growth hormone (GH).
- Short stature associated with specific genetic conditions like Turner syndrome, Noonan syndrome, and Prader-Willi syndrome.
- Short stature in children born small for gestational age (SGA) who fail to show catch-up growth by a certain age.
- Growth failure in pediatric patients with chronic renal insufficiency.
- Idiopathic Short Stature (ISS) in children.
- Adults with growth hormone deficiency (either childhood-onset or adult-onset).
Common Side Effects
Possible side effects include:
- Injection site reactions (pain, redness, itching).
- Headache.
- Joint or muscle pain.
- Swelling of hands or feet due to fluid retention (edema).
- Numbness or tingling sensation (carpal tunnel syndrome).
- Cold or flu-like symptoms.
Important Safety Information and Precautions
- Medical Supervision: The medication must be used under the guidance and prescription of a qualified healthcare professional. Do not self-administer without proper medical guidance.
- Contraindications: CinnaTrophin should not be used in patients with an active malignancy (cancer) or certain critical illnesses following surgery or trauma. It is also contraindicated in children with Prader-Willi syndrome who are severely obese or have severe breathing problems.
- Monitoring: Regular monitoring of blood sugar levels and growth progress is important during treatment. Patients should be evaluated for conditions like scoliosis, slipped capital femoral epiphyses, and intracranial hypertension.
Consult a doctor for the correct diagnosis, dosage, and administration instructions based on individual health needs.
₨ 10,000
